Journal
JOURNAL OF RADIATION ONCOLOGY
Volume 1, Issue 2, Pages 129-146Publisher
SPRINGER HEIDELBERG
DOI: 10.1007/s13566-012-0020-4
Keywords
Intensity-modulated radiation therapy; Nasopharyngeal carcinoma; Radiotherapy
Categories
Ask authors/readers for more resources
Introduction Advances in radiation therapy, such as intensity-modulated radiation therapy (IMRT), have allowed high-dose delivery to tumors while sparing normal tissues. However, IMRT requires careful delineation of target volumes to prevent marginal recurrences. Results and discussion This review discusses the recent advances in the treatment of nasopharyngeal carcinoma with particular emphasis on IMRT. Multiple phase III trials that have relied on conventional radiotherapy have shown a survival benefit to concurrent chemoradiotherapy (CCRT) over radiotherapy (RT) alone. Two randomized trials using IMRT have demonstrated decreased xerostomia rates compared to conventional radiotherapy while still maintaining excellent local control rates, although follow-up was short. While modern locoregional results are excellent, 90 % or more, distant-metastasis-free rates are not as impressive, ranging from 66 to 93 % among studies. Conclusion IMRT is an advanced technique, its excellent treatment outcomes have been reproduced in many single institution studies. Perhaps IMRT-delivered RT can replace the benefit provided by chemotherapy when added to conventional RT. Future studies should focus on reducing target volumes to minimize toxicity while dose-escalating for high-risk patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available